Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Intevac Inc. ( IVAC - Snapshot Report ) reported fourth quarter 2010 diluted earnings of 5 cents per share beating the Zacks Consensus Estimate of 3 cents per share. However, the EPS fell 44.4% year over year and 91.4% sequentially.
For full year 2010, Intevac reported diluted earnings per share of $1.22 which marginally went ahead of the Zacks Consensus Estimate for 2010 of $1.21 per share. This also compares favorably with the net loss of 46 cents in prior year and therefore a surge of 165.2%.
Management cited strong operational performance as the resultant for the strong yearly growth of the EPS. Management said that company’s highly flexible operational model showcased the ability of quick production to meet hard drive demand in the second and third quarter of the reported year.
The Quarter & The Year
Revenues for the quarter increased 5.8% from year ago quarter to $36.2 million and included $26.8 million of Equipment revenues and Intevac Photonics revenues of $9.4 million. The reported revenue was just short of Zacks Consensus Revenue Estimate of $37 million.
For 2010, Intevac reported revenue of $202.5 million which was fell short of Zacks Consensus Revenue Estimate of $204 million. Intevac’s full year revenue however increased 159.6% from prior year and included $168.3 million of Equipment revenues and Intevac Photonics revenues of $34.3 million.
Gross profit for the quarter decreased 4.6% year on year to $14.6 million. However gross profit for the year ended increased 168.2% to $87.7 million. Consolidated gross margin was 40.3% in the quarter compared with 44.6% in the same quarter previous year. For full year the gross margin advanced 1.3 percentage points compared with 2009 to 43.3%
Operating expense increased 29.5% year over year to $14.5 million in the quarter and for full year 2010 the operating expense increased 12.6% to $56.4 million. The yearly growth was mainly due to reinstatement of the company’s variable compensation programs
The Way Ahead
Management expects to launch several new products in 2011 for Equipment business and expand the product portfolio for the large and growing solar cell manufacturing market. The company expects to do so while maintaining technology and operational leadership in the hard disk drive media processing market.
In the next quarter, management also wants to ship the company’s first Lean Solar crystalline silicon deposition system, and expects to earn revenue on Continuum semiconductor mainframe shipments. Management further expects t ramp product based revenue from the Photonic business.
Conclusion
Estimates for the quarter, current year and for the next year had been stable in the run-up to the earnings release, with no analysts raising or lowering their estimates. The full-year estimate for next year remains at 82 cents.
We note that Intevac has consistently exceeded estimates over the past year or so. The average surprise in the preceding 4 quarters is a positive 161.08%, and another positive surprise was therefore expected.
We currently have a Zacks #3 Rank for Intevac which translates into a Hold rating, on short term basis. However, Intevac’s competitors, namely Entegris, Inc. ( ENTG - Snapshot Report ) , Brooks Automation Inc. ( BRKS - Snapshot Report ) and MKS Instruments Inc. ( MKSI - Snapshot Report ) , all have a Zacks #1 Rank which translates to Strong Buy rating on short term basis. For long term, we currently have a Neutral recommendation for Intevac.
Read the full Snapshot Report on BRKS
Read the full Snapshot Report on IVAC
Read the full Snapshot Report on MKSI
Read the full Snapshot Report on ENTG